ACRS - Aclaris Therapeutics GAAP EPS of -$0.42 beats by $0.03 revenue of $1.87M misses by $0.03M August, 07 2023 07:17 AM Aclaris Therapeutics Inc. 2023-08-07 07:17:26 ET Aclaris Therapeutics press release ( NASDAQ: ACRS ): Q2 GAAP EPS of -$0.42 beats by $0.03 . Revenue of $1.87M (+22.2% Y/Y) misses by $0.03M . For further details see: Aclaris Therapeutics GAAP EPS of -$0.42 beats by $0.03, revenue of $1.87M misses by $0.03M